Alterity Therapeutics Price Chart
Alterity Therapeutics Volume Chart
Alterity Therapeutics Market Segments
Regular Trading Hours
*No Trades in Segment
Premarket
+0.00(+0.00%)
| Open | $4.65 |
|---|---|
| Close | $4.65 |
| Low | $4.65 |
| Low Change | 0.00 (0.00%) |
| High | $4.65 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1K |
| Dollar Volume | $4.65K |
After Hours Yesterday
+0.00(+0.00%)
| Open | $4.55 |
|---|---|
| Close | $4.55 |
| Low | $4.55 |
| Low Change | 0.00 (0.00%) |
| High | $4.55 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 397 |
| Dollar Volume | $1.81K |
Regular Trading Hours Yesterday
+0.11(+2.33%)
| Open | $4.72 |
|---|---|
| Close | $4.83 |
| Low | $4.70 |
| Low Change | -0.02 (-0.42%) |
| High | $4.84 |
| High Change | +0.12 (+2.54%) |
| Range | $0.14 |
| Volume | 10.363K |
| Dollar Volume | $50.05K |
Premarket Yesterday
*No Trades in Segment
Alterity Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $4.70 |
|---|---|
| 10 Day Moving Average (SMA10) | $4.65 |
| 20 Day Moving Average (SMA20) | $4.56 |
| 50 Day Moving Average (SMA50) | $3.93 |
| 100 Day Moving Average (SMA100) | $3.62 |
| 200 Day Moving Average (SMA200) | $4.03 |
Alterity Therapeutics Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Alterity Therapeutics Stock Splits
There have been 2 stock splits for Alterity Therapeutics (ATHE). The last reverse stock split occured on January 9, 2023 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Jan 9, 2023 | Reverse | 10:1 |
| Mar 24, 2016 | Reverse | 6:1 |
Alterity Therapeutics Dividends
There have been no dividends for Alterity Therapeutics (ATHE).